stockrowDENTSPLY SIRONA Inc.
XRAY Healthcare Medical Instruments & Supplies
DENTSPLY SIRONA Inc.’s revenue for fiscal 2025 (year ended December 2025) was $3.7 billion, down 2.98% from fiscal 2024.
- Revenue
- −7.52%
- EPS
- +99.5%
- Free cash flow
- −18.0%
- Total debt
- −1.59%
Quarter to September 2026, against a year earlier
Follow XRAY
Alert me
DENTSPLY SIRONA Inc. (XRAY) Revenue growth
DENTSPLY SIRONA Inc.'s revenue growth over the twelve months to 30 September 2026 was −1.35%, up 1.6 percentage points from fiscal 2025 (−2.98%). Over the past ten years it has ranged from −17.0% (fiscal 2020) to 40.1% (fiscal 2016); the current reading is higher than 45% of that period. That is below the Medical Instruments & Supplies industry median of 8.97% and below the Healthcare sector median of 7.80%.
Revenue growth, annual
Embed this chart
Annual newest first
| Period | Revenue growth | Change (points) |
|---|---|---|
| FY2025 | −2.98% | 1.36 |
| FY2024 | −4.34% | (5.44) |
| FY2023 | 1.10% | 8.40 |
| FY2022 | −7.30% | (34.01) |
| FY2021 | 26.7% | 43.69 |
| FY2020 | −17.0% | (17.88) |
| FY2019 | 0.90% | 1.09 |
| FY2018 | −0.19% | (6.81) |
| FY2017 | 6.62% | (33.43) |
| FY2016 | 40.1% | 48.55 |
Quarterly newest first
| Period | Revenue growth | Change (points) |
|---|---|---|
| Sep 2026 | −7.52% | (3.46) |
| Jun 2026 | −4.06% | (4.17) |
| Mar 2026 | 0.11% | (6.08) |
| Dec 2025 | 6.19% | 11.13 |
| 43 more quarters | Free account |
Against its own ten years
Revenue growth against peers
| Company | Revenue growth |
|---|---|
| PLSE Pulse Biosciences, Inc compare | 90.1% |
| KMTS Kestra Medical Technologies, Ltd. compare | 60.7% |
| STAA STAAR Surgical Company compare | 42.4% |
| ATRC AtriCure, Inc. compare | 13.8% |
| LMAT LeMaitre Vascular, Inc. compare | 11.8% |
| STVN Stevanato Group S.p.A. compare | 11.6% |
| WRBY Warby Parker Inc. compare | 9.89% |
| AZTA Azenta, Inc. compare | 4.80% |
| XRAY DENTSPLY SIRONA Inc. | −1.35% |
| Medical Instruments & Supplies industry median | 8.97% |
| Healthcare sector median | 7.80% |
| Market median | 7.58% |
What Revenue growth is
Revenue Growth shows how fast a company’s sales are rising or falling compared with the same period a year earlier.
(Revenue − Revenue a year earlier) ÷ |Revenue a year earlier|
More on XRAY
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement